Markets News

Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.

TSMC ADR Premium Shrinks, Sparking 6% Slide in US Shares
Markets Daniel Marsh

TSMC ADR Premium Shrinks, Sparking 6% Slide in US Shares

TSMC's US shares dropped 6% as the premium over Taipei shares shrank sharply, indicating a flow-driven adjustment rather than a change in earnings outlook.

TSM NVDA MU
Nvidia Slips 3.6% as 362-kW Rack Highlights Power and Cooling Risks
Markets Daniel Marsh

Nvidia Slips 3.6% as 362-kW Rack Highlights Power and Cooling Risks

Nvidia shares fell 3.6% to $201.10 as a 362-kW rack system from Super Micro shifted investor focus to power and cooling constraints, with Morgan Stanley warning of grid bottlenecks in 2027-2028.

NVDA SMCI AVGO AMD
Viking Therapeutics Surges on Obesity Drug Hopes
Markets Daniel Marsh

Viking Therapeutics Surges on Obesity Drug Hopes

Viking Therapeutics shares climbed 6% to $34.30 as investors bet on upcoming Phase 3 data for its obesity drug VK2735, expected in Q3 2026.

VKTX LLY NVO
Focus Universal Surges After Reverse Split, but Fundamentals Questioned
Markets Daniel Marsh

Focus Universal Surges After Reverse Split, but Fundamentals Questioned

Focus Universal (FCUV) surged post-reverse split, but weak Q1 revenue and going concern doubts persist.

FCUV
Ambev Shares Rise on Payout, Rate Outlook, and World Cup Demand
Markets Daniel Marsh

Ambev Shares Rise on Payout, Rate Outlook, and World Cup Demand

Ambev shares rose 1.05% to 16.34 reais as a new payout and World Cup demand offset cautious rate signals. Q1 earnings showed 8.1% organic revenue growth.

Marvell Stock Slumps After S&P 500 Debut Amid AI Spending Doubts
Markets Daniel Marsh

Marvell Stock Slumps After S&P 500 Debut Amid AI Spending Doubts

Marvell Technology dropped 10% to $276.82 after joining the S&P 500, as chip stocks slid and AI spending concerns mounted.

MRVL NVDA INTC AMD AVGO MU
Pfizer Shares Dip as Key Lung Cancer Drug Fails Trial, Pressuring Growth Plans
Markets Daniel Marsh

Pfizer Shares Dip as Key Lung Cancer Drug Fails Trial, Pressuring Growth Plans

Pfizer shares slipped 0.8% after a key lung cancer drug from its Seagen acquisition missed survival goals in a late-stage trial, intensifying pressure on growth plans.

PFE MRK
Grab Faces Indonesia Fee Cut Test as Margins Tighten
Markets Daniel Marsh

Grab Faces Indonesia Fee Cut Test as Margins Tighten

Grab shares hover near $3.48 as Indonesia cuts ride-hailing commissions from 20% to 8% from July 1, pressuring margins. Investors eye volume growth and AI tools to offset profit risks.

GRAB UBER DASH
Aditxt Surges on New 10% Stake Filing Amid Financial Woes
Markets Daniel Marsh

Aditxt Surges on New 10% Stake Filing Amid Financial Woes

Aditxt shares soared after a new investor disclosed a 10.9% stake, but the company faces going-concern risks and a Nasdaq delisting appeal.

ADTX
Tesla Stock Tumbles on US Safety Probe and European Sales Concerns
Markets Daniel Marsh

Tesla Stock Tumbles on US Safety Probe and European Sales Concerns

Tesla shares fell 5% on a new US safety probe and tech selloff, despite a 108% surge in European sales. Q2 delivery report due July 2 adds investor risk.

TSLA RIVN LCID QQQ
Plug Power Shares Stagnate as Liquidity Milestone Looms
Markets Daniel Marsh

Plug Power Shares Stagnate as Liquidity Milestone Looms

Plug Power shares hover near $2.79 as the hydrogen firm races to close a critical asset sale by month-end to shore up liquidity, with the stock still down 39% from its peak.

PLUG
Robinhood Shares Dip After $2 Billion Debt Issuance
Markets Daniel Marsh

Robinhood Shares Dip After $2 Billion Debt Issuance

Robinhood shares slipped 0.6% after pricing a $2 billion convertible note sale, raising $1.97 billion for buybacks, capped calls, and growth initiatives.

HOOD IBKR SCHW